HL-300 not checked

Hangzhou Highlightll Pharmaceutical Co., Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
5 active
8 in total · 6 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Group A receives the investigational product at a concentration of 0.25%, BID,4 weeks.”In the company’s words, NCT07629778 on ClinicalTrials.gov
Tested for
Atopic Dermatitis
Main trialPhase 1/2
“This study is a randomized, double-blind, placebo-controlled, multicenter Phase Ib/II clinical study designed to evaluate the efficacy, safety, and PK characteristics of HL-300 ointment with different concentration regimens for mild-to-moderate AD.”In the company’s words, NCT07629778 on ClinicalTrials.gov

Other drugs for Atopic Dermatitis

All 90 drugs for Atopic Dermatitis

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 30 Jun 2027 HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Phase 1Completed 25 Nov 2024 HL-300 Ointment in Healthy Volunteers
Phase 3Authorised not given A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Phase 3Authorised not given A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure
Phase 3/4Ended not given The effects of the manipulation of 5-HT, DA and NA on exercise-induced fatigue and brain activation
Phase 2Not authorised not given A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE
Phase 2Authorised not given Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial
Phase 3Authorised not given Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter randomized controlled non-inferiority study (RIFREE)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow HL-300

Following is part of Solo: you see every change to HL-300 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in